QOLP-10. PATIENT-REPORTED OUTCOMES DURING TREATMENT FOR GLIOBLASTOMA: SYMPTOM BURDEN AND ASSOCIATED IMPACT ON DAILY LIFE

INTRODUCTION: Glioblastoma is the most common primary malignant brain tumor, with an annual incidence of 3–4 new cases per 100,000 people. Despite advances in chemotherapy, radiotherapy, and surgical interventions, prognosis remains poor. Aims of treatment for life-limiting diagnoses should extend b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Hultman, Meghan, Tipps, Megan, Liu, Minda, Banerji, Nilanjana, Bruns, Patricia, Trusheim, John
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Quality of Life and Palliative Care
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847620/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.830
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky